Similar Posts
NY Times “Postscript” to Scott Shane’s article on Ivins of Jan 4, 2009
A two-paragraph article in today’s NY Times, sans byline, appears to end discussion of the so-called “chemical signature” said to identify the source of water used to grow the anthrax letter spores: On Tuesday at an American Society for Microbiology conference in Baltimore, an F.B.I. scientist, Jason D. Bannan, said the water research ultimately was…
Study Links Plant Damage to Nanoparticles/NY Times blog
Thanks to Teresa Binstock for this tip– An exposure to nano-scale copper oxide particles stunted the shoots and roots of radishes and two species of rye grass.
Can the Vaccine Wars Get Any Weirder? Father of (Unvaccinated) Boy With Leukemia Asks California School Officials to Bar Unvaccinated Students/ NY Times
The son has been treated for leukemia and is still immune-compromised, has not received the live measles vaccine, as it might be dangerous for him. So the dad wants his child protected by forcing everyone else in the school to be vaccinated, to create a safe cocoon (at least while in school) for his child….
UK govt trying to stop compensation it already granted for Narcolepsy cases linked to GSK’s Pandemrix swine flu vaccine/ Guardian
Over 1,300 people who received the Pandemrix swine flu vaccine in 2009-10 developed narcolepsy. Demographically, adolescents were hardest hit. The vaccination caused profound neurologic disability and frequent personality changes in those affected. All governments that gave out swine flu vaccines were required (by manufacturers, the World Health Organization and pre-existing contracts that had been…
New review of anthrax case discussed by review committee vice chair, Stanford bioterrorism expert
David Relman, vice chair of the National Academy of Science committee that reported on the FBI’s anthrax letters research last week, did some clearer speaking (compared to the committee report and his statements at the NAS press conference on 2/15) about the committee’s findings for a press release from Stanford University, where he is a…
Glaxo pays the USG $750 million for selling tainted drugs–but no patients were (officially) harmed, of course,
Excerpts from Bloomberg: GlaxoSmithKline Plc agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The affected drugs included the antidepressant Paxil CR and the diabetes treatment Avandamet. “We regret that we operated the Cidra facility in a manner that was inconsistent with current Good Manufacturing Practice…